Journal for ImmunoTherapy of Cancer (Nov 2021)

148 Primary or iPSC-derived cell-based cytotoxicity assays to assess potential safety risks of engineered T cell therapies in vitro

  • Gemma Moiset,
  • Sophie Vermond,
  • Monique Hazenoot,
  • Rene McLaughlin,
  • Sabrina de Munnik,
  • Marco Guadagnoli,
  • Sanne Holt,
  • Marijn Vlaming

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.148
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.